Bundibugyo Ebola: when no approved vaccines exists, early detection becomes critical.
Release Date 2026-05-26

Bundibugyo virus disease (BVD) is a severe form of Ebola disease that can spread from infected wildlife to humans, followed by person-to-person transmission through direct contact with blood or bodily fluids. 

 

Because early symptoms - including fever, fatigue, headache, and muscle pain - are often non-specific, rapid molecular testing plays a key role in outbreak response. 

 

To support laboratories facing emerging infectious disease challenges, Tianlong introduces: 

 

Ebola Virus (Bundibugyo) Nucleic Acid Detection Kit (Fluorescence PCR Method)

• Compatible with whole blood, serum, and plasma

• Sensitivity: 500 copies/mL

• Precision: CV ≤5%

• No cross-reactivity with Ebola (Zaire), Ebola (Sudan), etc.

 

Tianlong also provides PCR detection solutions for Ebola virus (Zaire) and Ebola virus (Sudan).

 

When there’s no cure, early diagnosis matters most. Tianlong stands ready to help labs respond faster, smarter, and with confidence.


Share
Recommendation